ARCHIVEPrevenar13 Ball of Life Turns a Childhood Vaccine Into Ambient Art
Ball of Life is an ambient disease-awareness campaign created for the pneumococcal vaccine brand Prevenar13 by Kuala Lumpur agency Alpha 245, published in Malaysia in December 2013, using a single physical installation to communicate the stakes of pneumococcal infection to a general audience.
The campaign entered the market at a moment when pharmaceutical narrative advertising in Malaysia was moving beyond the clinical and toward the experiential. Ambient media — installations and environmental interventions encountered in everyday space rather than on a screen — offered Prevenar13 a way to generate emotional proximity to a disease that is largely invisible to healthy adults. The brief, as archived on Clapboard, called for work in the innovative-media and disease-awareness category, and Alpha 245 answered it with a single, self-contained creative asset that could be physically encountered rather than merely viewed.
In Malaysia, where childhood immunisation coverage and public health literacy are ongoing policy priorities, translating the complexity of pneumococcal disease into an immediate, legible experience represented a meaningful creative challenge. The campaign did not rely on paid broadcast media or digital targeting. Instead, it placed its entire argument inside one object — the ball — allowing the concept to function as both metaphor and mechanism. That formal economy is what ultimately earned Ball of Life a shortlist position at the Clio Health 2013 awards in the Innovative Media and Disease Awareness category, as confirmed by the Clio Health archive. The Clapboard Score for this campaign is 63 out of 100, reflecting the strength of its conceptual foundation against the limitations of a single-asset execution with no independently verified reach data.
ARCHIVEPrevenar13 occupied the category-leadership position in the global pneumococcal conjugate vaccine segment around 2013. According to FiercePharma, Pfizer reported approximately $3.974 billion in combined Prevnar franchise sales for 2013, a figure that underlines the commercial scale behind the brand even as it pursued localised awareness activity in markets such as Malaysia. That scale came with competitive pressure: GSK's Synflorix and Merck's Pneumovax 23 were both active in the same category, targeting overlapping paediatric and adult populations, as noted across pharmatimes.com and FiercePharma reporting on the period.
In Malaysia specifically, the strategic rationale for an ambient approach becomes clear when the audience is considered. Caregivers making vaccination decisions are not primarily moved by product specifications — they respond to emotional stakes. Alpha 245 appears to have identified that gap and built the campaign around it, translating pneumococcal disease from a clinical abstraction into something that could be held, looked at, and understood in a single encounter. Ambient media, by its nature, removes the option of scrolling past. It demands a moment of attention from whoever enters its physical space, which made it a tactically astute choice for a healthcare message that depends on comprehension rather than mere exposure.
By January 2013, Prevenar13 had received paediatric approval in nearly 120 countries, according to Pfizer's own published records, which meant that in Malaysia the communications task was less about regulatory legitimacy and more about driving motivated uptake among parents and caregivers who may have perceived pneumococcal disease as a distant threat rather than an immediate one.
Ball of Life rests its entire creative argument on one object. That choice — to compress a pharmaceutical disease-awareness message into a single ambient artefact — is both the campaign's greatest formal risk and its most distinctive quality. The ball functions simultaneously as a familiar childhood symbol and as a vehicle for communicating vulnerability, making the connection between play, life, and the threat of pneumococcal disease legible without clinical language or instructional copy.
Production credits for Ball of Life are not publicly documented in any trade press archive or agency portfolio reviewed for this case study. The Clapboard archive records one media asset associated with the campaign, confirming the deliberate economy of the execution. What can be assessed from the archived asset is the visual and conceptual discipline with which Alpha 245, based in Kuala Lumpur, approached the brief. The installation does not attempt to do more than its concept requires. Ambient work of this kind succeeds or fails on the precision of its central idea, and the decision to anchor the entire message to a single object — legible across language barriers and educational backgrounds — reflects a clear-eyed understanding of how non-captive audiences process information in physical space.
The narrative strategy embedded in the execution is worth noting in its own right. Rather than presenting Prevenar13 as a product to be prescribed, Ball of Life frames the vaccine in terms of what it protects: the ordinary, joyful, embodied life of a child. That reframing — from pharmaceutical intervention to guardian of lived experience — is consistent with the broader direction that healthcare advertising in Malaysia and across the Asia-Pacific region was taking in the early 2010s, moving away from symptom-led messaging toward emotionally resonant storytelling.
Ball of Life earned a shortlist position at the Clio Health 2013 awards in the Innovative Media and Disease Awareness category, as confirmed by the Clio Health archive. The campaign did not take the category prize, but shortlist recognition at Clio Health — one of the most closely watched awards programmes in pharmaceutical and healthcare advertising globally — represents meaningful independent validation of the creative work produced by Alpha 245 for Prevenar13 in Malaysia.
No verified performance data for Ball of Life is publicly available. No sales lift, vaccination-uptake movement, brand-tracking change, awareness metric, or reach figure has been identified in any trade press source, agency case study, or independent review. This absence is not unusual for a single-asset ambient campaign deployed in one market in 2013; ambient work of this nature rarely generates the kind of measurable digital trail that subsequent campaign reporting depends on.
What the structural evidence does support is a campaign that made a disciplined and coherent creative bet. A single ambient asset, shortlisted at an international healthcare awards programme, produced in Kuala Lumpur for a category-leading vaccine brand competing against GSK's Synflorix and Merck's Pneumovax 23, represents a resource-efficient approach to disease-awareness communication. The Clapboard Score of 63 out of 100 reflects exactly this balance: strong conceptual integrity and independently recognised creative quality, offset by the inherent limitations of a one-asset execution without verified audience impact data.
Ball of Life is a disease-awareness ambient campaign created for Prevenar13 by Alpha 245 in Malaysia in December 2013. It uses a single physical installation to communicate the importance of pneumococcal vaccination. The campaign earned a shortlist at the Clio Health 2013 awards in the Innovative Media and Disease Awareness category.
Alpha 245, a Kuala Lumpur-based advertising agency, created Ball of Life for Prevenar13. The campaign was published in Malaysia in December 2013 and comprises a single ambient media asset, as recorded in the Clapboard archive. No additional production credits are publicly documented in any available trade press source.
Ball of Life was shortlisted at Clio Health 2013 in the Innovative Media and Disease Awareness category, as confirmed by the Clio Health archive. The campaign did not take the category prize. Shortlist recognition at Clio Health represents independent validation of the creative work Alpha 245 produced for Prevenar13 in the Malaysian market.
Prevenar13 is Pfizer's pneumococcal conjugate vaccine, which held category-leadership status around 2013. Its principal competitors in the same period were GSK's Synflorix and Merck's Pneumovax 23, as reported by FiercePharma and pharmatimes.com. By January 2013, Prevenar13 had received paediatric approval in nearly 120 countries, according to Pfizer's published records.
Ball of Life holds a Clapboard Score of 63 out of 100. The score reflects the campaign's strong conceptual foundation and its Clio Health 2013 shortlist recognition, balanced against the constraints of a single-asset ambient execution and the absence of any publicly verified audience reach or vaccination-uptake data for the Malaysian market.
Alpha 245 used ambient media because it removes the option of passive avoidance, demanding a moment of genuine attention from anyone who encounters the installation. In Malaysia, where caregivers needed to connect emotionally with the stakes of pneumococcal disease rather than absorb clinical data, a physical object offered immediacy that broadcast or digital formats could not replicate.
.webp)
Creative Collaboration Platform: The Backbone of Modern Creative WorkWhat is a creative collaboration platform?Clapboard defines a creative collaboration platform as the operational core for today’s distributed creative teams. This is not a collection of digital collaboration tools stitched together; Clapboard’s system
Understanding the Creative Production MarketplaceWhat is a Creative Production Marketplace?Clapboard defines a creative production marketplace as a structured ecosystem where brands, agencies, and production talent converge to execute video, advertising, and branded content at scale. Unlike the legacy agency or freelanREAD FULL ARTICLE
The Urgent Need for a Creative Production Operating SystemWhy Traditional Creative Production Models Break DownClapboard sees the creative production landscape shifting under pressure. Content velocity is no longer a buzzword—it’s a mandate. Modern advertising demands relentless output across dozens of channels, each wREAD FULL ARTICLE
